Terns Pharmaceuticals, Inc. Common Stock
Symbol: TERN (NASDAQ)
7.99
▲ (2.36%) 0.184
Company Description:
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Key Stats
- Today's Open: $7.8
- Today's High: $8.045
- Today's Low: $7.706
- Today's Volume: 243.03K
- Yesterday Close: $7.81
- Yesterday High: $8.09
- Yesterday Low: $7.45
- Yesterday Volume: 1.17M
- Last Min Volume: 976
- Last Min High: $7.979
- Last Min Low: $7.975
- Last Min VWAP: $7.97533
Company Profile
- Name: Terns Pharmaceuticals, Inc. Common Stock
- Website: https://www.ternspharma.com
- Listed Date: 2021-02-05
- Location: FOSTER CITY, CA
- Market Status: Active
- CIK Number: 0001831363
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $683.46M
- Round Lot: 100
- Outstanding Shares: 87.51M
- Asset Type: CS
RECENT FILINGS FOR TERN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-16 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-05-23 | EFFECT | View |
| 2025-05-21 | CORRESP | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | UPLOAD | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on TERN